Bortezomib / Cyclofosfamide / Dexamethason (VCD) - Multipel Myeloom

Middelen Bortezomib Cyclofosfamide Dexamethason

Bortezomib / Dexamethason / Panobinostat - Multipel Myeloom (recidief en/of refractair)

Middelen Bortezomib Dexamethason Panobinostat

Bortezomib / Doxorubicine / Dexamethason (PAD) - Multipel Myeloom

Middelen Bortezomib Dexamethason Doxorubicine

Bortezomib / Melfalan / Prednisolon (MPV) 1x per week - Multipel Myeloom

Middelen Bortezomib

Bortezomib / Melfalan / Prednisolon (MPV) 2x per week - Multipel Myeloom

Middelen Bortezomib

Bortezomib / Pomalidomide / Dexamethason - Multipel Myeloom recidief

Middelen Bortezomib Dexamethason Pomalidomide

Bortezomib / Thalidomide / Dexamethason (VTD) - Mutipel Myeloom

Middelen Bortezomib Dexamethason Thalidomide

Bortezomib 1x per week - Multipel Myeloom

Middelen Bortezomib

Bortezomib 2x per week - Multipel Myeloom

Middelen Bortezomib

Carfilzomib / Dexamethason (wekelijks) - Multipel Myeloom

Middelen Carfilzomib Dexamethason

Carfilzomib / Dexamethason - Multipel Myeloom recidief

Middelen Carfilzomib Dexamethason

Carfilzomib / Lenalidomide / Dexamethason - Multipel Myeloom

Middelen Carfilzomib Dexamethason Lenalidomide

Cyclofosfamide / Doxorubicine / Dexamethason (CAD)

Middelen Cyclofosfamide Dexamethason Doxorubicine

Daratumumab subcutaan (onderhoud na Daratumumab VMP) - Multipel Myeloom

Middelen Daratumumab

Daratumumab subcutaan / Bortezomib / Dexamethason - Multipel Myeloom

Middelen Bortezomib Daratumumab Dexamethason

Daratumumab subcutaan / Bortezomib / Lenalidomide / Dexamethason (Daratumumab sc-VRD) - Multipel Myeloom

Middelen Bortezomib Daratumumab Dexamethason Lenalidomide

Daratumumab subcutaan / Bortezomib / Lenalidomide / Dexamethason (Daratumumab sc-VRD) kuur 5 + 6 na ASCT - Multipel Myeloom

Middelen Bortezomib Daratumumab Dexamethason Lenalidomide

Daratumumab subcutaan / Bortezomib / Thalidomide / Dexamethason (Daratumumab sc-VTD) - Multipel Myeloom

Middelen Bortezomib Daratumumab Dexamethason Thalidomide

Daratumumab subcutaan / Carfilzomib / Dexamethason (KRD)- Multipel Myeloom recidief

Middelen Carfilzomib Daratumumab Dexamethason

Daratumumab subcutaan / Dexamethason - Multipel Myeloom

Middelen Daratumumab Dexamethason

Daratumumab subcutaan / Lenalidomide / Dexamethason - Multipel Myeloom

Middelen Daratumumab Dexamethason Lenalidomide

Daratumumab subcutaan / Pomalidomide / Dexamethason - Multipel Myeloom recidief

Middelen Daratumumab Dexamethason Pomalidomide

Daratumumab subcutaan / Velcade / Melfalan / Prednison (VMP) - Multipel Myeloom

Middelen Bortezomib Daratumumab Melfalan

Elotuzumab / Lenalidomide / Dexamethason - Multipel Myeloom

Middelen Dexamethason Elotuzumab Lenalidomide

Elotuzumab / Pomalidomide / Dexamethason (EPD) - Multipel Myeloom

Middelen Dexamethason Elotuzumab Pomalidomide

Ixazomib / Lenalidomide / Dexamethason - Multipel Myeloom

Middelen Dexamethason Ixazomib Lenalidomide

Lenalidomide (om de dag) - Multipel Myeloom

Middelen Lenalidomide

Lenalidomide / Dexamethason - Multipel Myeloom

Middelen Dexamethason Lenalidomide

Teclistamab subcutaan - Multipel Myeloom

Middelen Teclistamab